SCHEMBL4183638

SCHEMBL4183638

COc1ccccc1/C=C(\C#N)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.54
KDM4E B2RXH2 3/20 0.54
KMT2A Q03164 3/20 0.54
PKM P14618 1/20 0.54
ALDH1A1 P00352 6/20 0.53
HPGD P15428 1/20 0.53
RECQL P46063 1/20 0.53
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
MAPK1 P28482 1/20 0.44
PTK2B Q14289 1/20 0.44
NFE2L2 Q16236 1/20 0.43
MAPT P10636 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
SLC16A3 O15427 1/20 0.42
SLC16A1 P53985 1/20 0.42
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183640 1.00 LMNA (0.54) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL4183643 1.00 LMNA (0.54) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL4188797 0.93 KMT2A (0.49) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL4188795 0.93 KMT2A (0.49) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL4188791 0.93 KMT2A (0.49) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL4168012 0.87 ALDH1A1 (0.54) LMNAKDM4EKMT2AALDH1A1HPGD
SCHEMBL4176478 0.87 ALDH1A1 (0.51) LMNAKDM4EKMT2AALDH1A1HPGD
SCHEMBL4176471 0.87 ALDH1A1 (0.51) LMNAKDM4EKMT2AALDH1A1HPGD
SCHEMBL4176474 0.87 ALDH1A1 (0.51) LMNAKDM4EKMT2AALDH1A1HPGD
SCHEMBL4168014 0.87 ALDH1A1 (0.54) LMNAKDM4EKMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 LMNA 4621/4885KDM4E 1688/4885KMT2A 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.